Company Filing History:
1 out of 261 
1 out of 1,591 
Years Active: 2013
Title: Jochen Schneider: Innovator in Metabolic Syndrome Treatment
Introduction
Jochen Schneider is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of medicine, particularly in the treatment of metabolic syndrome. His innovative approach utilizes chloroquine, a compound traditionally used for malaria treatment, to address various metabolic disorders.
Latest Patents
Schneider holds a patent for the "Use of chloroquine to treat metabolic syndrome." This invention provides methods and compositions for modulating certain metabolic processes and treating disorders associated with metabolic syndrome. These disorders include insulin-related issues, ischemia, oxidative stress, atherosclerosis, hypertension, obesity, abnormal lipid metabolism, and stroke. The patent outlines the administration of an effective dose of a chloroquine compound, either alone or in combination with other pharmaceutically active ingredients.
Career Highlights
Throughout his career, Jochen Schneider has worked with prestigious institutions such as St. Jude Children's Research Hospital and Washington University. His work has focused on advancing medical treatments and improving patient outcomes in metabolic health.
Collaborations
Some of Schneider's notable coworkers include Michael B. Kastan and Clay F. Semenkovich. Their collaborative efforts have contributed to the advancement of research in metabolic syndrome and related fields.
Conclusion
Jochen Schneider's innovative work in utilizing chloroquine for treating metabolic syndrome showcases his commitment to improving healthcare solutions. His contributions are paving the way for new treatment methodologies that could benefit many individuals suffering from metabolic disorders.